Computer generated degenerative brain (DBrain) solution for people with memory loss and related impairements
People with dementia brain (DBrain) have acquired global impairments of the intellect, memory and personality. In Malaysia alone there are estimated 100,000 sufferers of dementia. Presently about 26.6 million people worldwide have dementia related diseases. By 2020, this is expected to rise to 34...
| Main Authors: | , , , , , |
|---|---|
| Format: | Conference or Workshop Item |
| Language: | English |
| Published: |
2010
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/23090/ http://irep.iium.edu.my/23090/1/p22.pdf |
| Summary: | People with dementia brain (DBrain) have acquired global impairments of the intellect, memory and
personality. In Malaysia alone there are estimated 100,000 sufferers of dementia. Presently about 26.6
million people worldwide have dementia related diseases. By 2020, this is expected to rise to 34 million
and 104 million by 2050.. The development of computer generated DBrain solution of pseudo-codes with
expressions of natural gene sequences aims to explore other dementia-related novel genes and overcome
the ethical and data protection issues The invention is the computer creation of artificial gene or pseudogene
codes through a completed fundamental research funded by MOHE under FRGS 2007-2008. The
invention is based on the phenomenon of recursive inter-molecular energy jumps between nucleotides.
The molecular -mechanism approach attempts to represent the process of brain receptor proteins
inhibiting neural transmission which may unravel decades of brain degeneration puzzles. The idea is to
discover the novel receptor genes in the brain mitochondria that are responsible for modulating the
inhibiting functions of a class of receptor proteins. Groups of the computer generated pseudo-gene
sequences are found to have high fitness ratios of the natural gene motifs of animal and a human GABAR
dementia related gene sequence. Patent for DBrain solution was filed in July 2009. The invention is being
pre-commercialized by a local Industrial partner, Niche Frontiere a manufacturer of service robots
through a MOSTI funded collaborative technofund project for the period 2009-2011. In this project more
pseudo-gene sequences with high fitness ratios of natural DNA motifs will be generated by high speed
computing grid of MIMOS-UTP and used by Niche-Frontiere’s diagnostic, therapeutic and treatment
multi-agents for dementia people at the clinical and firm levels. Through this collaborative precommercialization
project, the pseudo-gene sequences are also used by laboratories in USM and UTM to
discover novel herbal drugs and inhibitor receptor proteins as on-line databases for the service robots. |
|---|